CClinicalTrials.gg
RecruitingNCT07591311QIP in hipUpdated Sep 2, 2026

The Quadro-Iliac Plane (QIP) Block in Hip Surgery

An observational study in Hip Surgery and Hip Arthroplasty, sponsored by San Giovanni di Dio Hospital. Recruiting at 2 sites in Italy. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by San Giovanni di Dio Hospital · Observational

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
80
Sex
All
01

Study summary

The goal of this observational study is to learn about the effectiveness of different locoregional anesthesia techniques, particularly the Quadro-Iliac Plane (QIP) block, in patients undergoing hip surgery, including arthroplasty. The main question it aims to answer is:

Does the QIP block improve postoperative recovery and pain control compared to other routinely used locoregional anesthesia techniques in patients undergoing hip surgery?

Participants undergoing hip surgery as part of their standard clinical care will receive one of the locoregional anesthesia techniques already in use at the hospital (including QIP block, fascia iliaca block, PENG block, or others, according to anesthesiologist choice). Postoperative outcomes will be collected prospectively, including quality of recovery (QoR-15 at 24 hours), pain scores at rest and during movement at predefined time points up to 48 hours, analgesic consumption, time to first analgesic request, time to mobilization, and occurrence of complications.

Read the detailed description

This prospective, observational, non-interventional clinical study will evaluate postoperative recovery and analgesic outcomes in adult patients undergoing hip surgery who receive locoregional anesthesia techniques already used in routine clinical practice.

The study focuses particularly on the Quadro-Iliac Plane (QIP) block, a recently introduced fascial plane block performed at the posterior-inferior aspect of the quadratus lumborum muscle near its insertion on the iliac crest. The QIP block will be assessed in comparison with other locoregional techniques routinely used for hip surgery, including fascia iliaca block, PENG block, sacral or lumbosacral erector spinae plane block, femoral nerve block, sciatic nerve block, lumbar plexus block, neuraxial anesthesia, or combinations of these techniques.

Patients will not be randomized, and the choice of anesthetic and analgesic technique will be made by the attending anesthesiologist according to standard clinical practice. All blocks will be ultrasound-guided and performed under aseptic conditions using approved local anesthetics. Standard perioperative monitoring, spinal anesthesia when appropriate, postoperative multimodal analgesia, and rescue analgesia will be provided according to institutional protocols.

The primary endpoint will be postoperative quality of recovery, assessed using the Quality of Recovery-15 score 24 hours after surgery. Secondary outcomes will include postoperative pain scores at rest and during movement at predefined time points up to 48 hours, patient satisfaction, total analgesic consumption, time to first rescue analgesic request, time to first mobilization, nausea and vomiting, antiemetic use, and block-related or postoperative adverse events. Safety monitoring will include immediate complications during block performance, early post-block complications, and delayed neurological symptoms assessed up to 7 days after surgery.

The study plans to include at least 40 patients, with a possible sample size of 40-80 cases, and an expected maximum study duration of 18 months.

02

Conditions studied

  • Hip Surgery
  • Hip Arthroplasty

Browse trials for

Keywords

  • regional anesthesia
  • hip
  • hip fracture
  • QIP
  • hip arthroplasty
03

In context

Hip Fractures

822 studies on the registry are indexed under Hip Fractures; 160 are open to participants now.

This study's planned enrollment of 80 is below the median of 140 across 268 observational studies indexed under Hip Fractures.

Browse Hip Fractures studies →

Lead sponsor

San Giovanni di Dio Hospital is the lead sponsor of 3 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing hip arthroplasty surgery, either elective or for a proximal femoral fracture

Inclusion criteria

  • Age ≥ 18 years
  • Patients undergoing hip surgery, either elective or for a proximal femoral fracture
  • Expected postoperative hospital stay ≥ 24 hours
  • ASA physical status I-III
  • Neuraxial and/or locoregional anesthesia according to standard clinical practice
  • Provision of informed consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Absence of informed consent
  • Contraindications to locoregional and/or spinal anesthesia
  • Allergy to local anesthetic agents
  • Cognitive impairment preventing reliable assessment of outcomes
  • Coagulation disorders and/or platelet abnormalities
  • Antiplatelet or anticoagulant therapy that contraindicates spinal anesthesia
  • Presence of localized infection or sepsis at the sites to be treated
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • QIP

    Quadro-Iliac Plane Block

    Procedure: Fascia iliaca block (FIB)

Interventions

  • ProcedureFascia iliaca block (FIB)

    Fascia Iliaca Block

06

What researchers measure

Primary outcomes

  1. Quality of Recovery (QoR)-15 score

    The Quality of Recovery-15 (QoR-15) is a validated patient-reported outcome measure designed to assess the quality of postoperative recovery across multiple dimensions of physical and psychological well-being. The questionnaire consists of 15 items, each scored on an 11-point numerical scale, resulting in a total score ranging from: Minimum score: 0 → extremely poor quality of recovery Maximum score: 150 → excellent quality of recovery Higher QoR-15 scores indicate a better postoperative recovery experience. The questionnaire evaluates five key domains: Pain Physical comfort Physical independence Psychological support Emotional state

    Time frame: 24 hours postoperatively

Secondary outcomes

  1. Postoperative Pain

    The Numerical Rating Scale (NRS) is a validated and widely used tool for the assessment of pain intensity in clinical practice and perioperative research. Patients are asked to rate their pain on a numerical scale ranging from: 0 → no pain 10 → worst pain imaginable

    Time frame: 0-2-4-6-8-12-24-48 hours after surgery

  2. First analgesia request

    Duration of analgesia

    Time frame: up to 48 hours

  3. First mobilization

    First mobilization of the patient after surgery

    Time frame: 24 hours postoperatively

  4. Complications

    Toxicity, PONV, others

    Time frame: up to 48 hours

07

Study locations

2 of 2 sites recruiting
08

References and documents

Study documents

  • Study protocol · Apr 27, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07591311
Lead sponsor
San Giovanni di Dio Hospital
Responsible party
Tommaso Sorrentino (Principal Investigator, San Giovanni di Dio Hospital) — Principal investigator
First posted
May 15, 2026
Start date
May 4, 2026
Primary completion
Jun 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Sep 2, 2026

Study contacts

Tommaso Sorrentino, MD
Contact
dr.sorrentinotommaso@gmail.com
+393277038017

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion